Antibodies, or immunoglobulins, have maintained a remarkably conserved structural feature throughout evolution: two identical antigen-binding sites. Although nature offers examples of highly effective monovalent receptors, such as T-cell receptors and certain innate immune sensors, the persistence of immunoglobulin divalence has long puzzled immunologists. A study now provides evidence that this ancient design is essential for how B cells sense and respond to antigens.
Using engineered B-cell antigen receptors (BCRs) that were rendered monovalent, researchers found a striking impairment in receptor signaling and antigen internalization. Through the use of super-resolution microscopy, the team showed that the physical clustering of BCRs on the plasma membrane dictates the strength of downstream activation. In essence, B cells interpret the scale of receptor clustering as a measure of antigen valence, translating small structural differences into distinct cellular responses.
Adding additional immunoreceptor tyrosine-based activation motifs to compensate for lost clustering did not improve sensitivity. This indicates that BCR signaling operates within a finely tuned dynamic range, where even subtle changes in receptor organization can drive profound biological outcomes.
The findings also provide an evolutionary rationale for antibody divalence: membrane-bound immunoglobulin precursors (the BCR isoforms) must be divalent to function properly. This requirement likely shaped the evolutionary conservation of the antibody’s two-armed structure. The authors propose that BCR divalence enhances the immune system’s ability to detect low-valence antigens thereby increasing the overall sensitivity and effectiveness of humoral immunity.
This work further unites principles across immune receptor families, suggesting that BCRs, FcεRI, and even synthetic chimeric antigen receptors share a common activation logic.